Roche Advances Infectious Disease Diagnostic Portfolio with US$1.8 B GenMark Acquisition
By Debadrita Paul & Michelle Liu
Pharma Deals Review: Vol 2021 Issue 4 (Table of Contents)
Published: 9 Apr-2021
DOI: 10.3833/pdr.v2021.i4.2605 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Roche has agreed to acquire GenMark, a multiplex molecular diagnostic (MD) solutions provider for infectious diseases, including bloodstream, respiratory and gastrointestinal infections...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS